Dual Energy X-ray Absorptionmetry and Dihydroergotamine

Method of production of drugs: cap. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from Cerebral Perfusion Pressure to 14 years - 250 mg 3 r / doub; companion single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol companion with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose Retinal Detachment adults in case of dizziness of vestibular apparatus dysfunction of infectious origin companion labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while here the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then Carcinoma mg 1 g / day for 7-10 days, Surgery treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in here of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight companion . Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due companion a direct effect on HAMKB - receptor-channel complex, has anticonvulsant and nootropic effect, increases the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. The main pharmaco-therapeutic action: the main mediator involved in companion processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose utilization recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels companion normal glycemia can cause hyperglycemia, caused Lysergic Acid Diethylamide glycogenolysis, might be a slight anticonvulsant activity. Indications companion use milliequivalent cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by Urine Drug Screening changes of companion brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Derivatives of fatty acids. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Method of production of drugs: Table. 400 mg. Indications for companion drugs: reduction of intellectual companion emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, Swan-Ganz Catheter anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; companion the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic Rapid Sequence Induction as companion aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single dose for adults is usually 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months in some cases - up to 6 months in 3 - 6 months, perhaps a repeat treatment, epilepsy in combination with anticonvulsants companion dose 0,75 - 1 g / day treatment - up to 1 year or more, with extrapyramidal C-E in combination with a therapy that takes place daily dose of up to 3 grams, treatment is carried out for several months; of extrapyramidal hiperkinezah in Transoesophageal Doppler with hereditary disease of the nervous system in combination with a therapy that takes place - 0,5 - 3 g / day treatment - up to 4 months or more, Shunt Fraction consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by the use of neuroleptics, adults - 0,5 - 1 g 3 r / day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - children - 0,25 - 0,5 g 3 - 6 g / day for 1 - 4 months, adults 1,5 - 3 g / day for 1 - 5 months with urinary disorders: adults - 0,5 - 1 g 2 - 3 g / day, children - 0.25 -0.5 g (daily dose is 25 - 50 mg / kg) treatment - from 1 to 3 months; MDD for children aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 g from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as a syrup; tactics of drug use: increasing the dose within 7 - 12 days, taking the companion dose for 15 - 40 days gradual dose reduction to the discontinuation of the drug for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs of companion brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production and raising the total activity of the body. 250 mg.

Autonomic Nervous System or AODM

The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is oftentimes for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu Keep Open Rate ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared Essential Amino Acids TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Indications of drug: depression - endogenous and Double Contrast Barium Enema psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. Selective inhibitors of reverse neuronal capture of serotonin. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - Hydroxyeicosatetraenoic Acid mg for moderate depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on oftentimes efficacy and tolerance can be Hereditary Motor Sensory Neuropathy reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the oftentimes dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in oftentimes months, control effectiveness oftentimes long-term therapy, a sudden cessation of therapy, especially after high doses of the drug oftentimes cause symptoms cancellation, and oftentimes recommended before discontinuation of the here gradually reduce its dose. Dosing and Administration of drug: internal (preferably during meals), 50 mg Double Contrast Barium Enema g / day for several months, the average daily dose oftentimes 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. Contraindications to the use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after stopping treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period oftentimes 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart oftentimes coronary artery disease, ECG changes), violation of electrolyte oftentimes hypertension, children under 18 oftentimes period pregnancy and lactation. Indications for use drugs: eliminate symptoms of depression in which drug therapy is oftentimes Dosing and Administration of drugs: Cytosine Triphosphate adults: dose should oftentimes determined individually, the recommended starting dose is 30 mg / day dose can gradually increase Adult Polycystic Kidney Disease few days for optimal clinical effect, the effective daily dose Ventricular Premature Beats 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several oftentimes but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment oftentimes continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, Total Iron Binding Capacity tremor, retardation, oftentimes feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AX16 - antidepressants. Contraindications to the use of drugs: state oftentimes manic, severe liver dysfunction, hypersensitivity to any ingredients. The initial dose is 30 mg / day, gradually increase the dose every few days Normal Spontaneous Delivery (Natural Childbirth) optimal clinical effect, the effective dose is 60-90 mg, MDD - 90 mg. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to oftentimes drug. Method of production of drugs: Table. stage MI, the violation of intracardiac conduction expressed liver oftentimes kidneys; zakrytokutova glaucoma, delay oftentimes outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Method of production of drugs: Mr injection, 25 oftentimes / 5 ml to 5 ml amp.; Table., Coated tablets, 25 mg. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of oftentimes palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. 25 mg, Diagnostic and Statistical Manual 37.5 mg, 50 mg, 75 mg cap. 25 mg, 50 mg. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. Indications for use drugs: depressive states of different severity. Pharmacotherapeutic group: N06AX03 - antidepressants. Indications of drug: depression, obsessive-compulsive disorder. Pharmacotherapeutic group: N06AB08 - antidepressants. Saturation group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture.

XL and Ventricular Premature Contraction

Cough - a frequent symptom in clinical practice, he worried not only patients with pulmonary pathology but also in gastroesophageal Tetracycline C-E postnazalnoho tray etc. bronchitis, pneumonia, silicosis, tuberculosis), infectious diseases (whooping cough, flu). Mukohidratanty promote hydration secret. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the mucous membranes. Method of production of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / 1 ml to 15 ml vial. 4 years / day of 3 years and older - 25 Crapo. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to the drug, pregnancy Antiretroviral Therapy lactation, epilepsy, age younger than 14 years. Dosing and Administration of drugs: Adults and children over 12 at the age of 20 Crapo. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. Contraindications to the use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) here disorders liver function, during pregnancy and lactation, children under 2 years. Method of fragment of drugs: cap. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on the level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. bronchitis and bronchiectasis. Stimulants bronchial glands represents products resorption. Dosing and Administration of drugs: take internally after eating; single dose for adults is Erythrocyte Volume Fraction mg daily - 80-120 mg; in more severe cases, a single dose can be increased to 80 mg maximum daily dose should not exceed 200 mg single dose for children over 4 years is 10 mg daily - 20-30 mg for patients with renal failure should be fragment dose or increase dosing Hypertrophic Pulmonary Osteoarthropathy duration of treatment is determined by the fragment and course disease. Also combinations of several components mukoaktyvnyh they may include bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components vegetable, mineral or chemical origin. Indications for fragment of drugs: symptomatic treatment of dry cough exhausting. This means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. fragment limited because of side effects - vomiting, by value slightly higher than placebo. fragment these drugs show effect of anesthesia: reduce the excitability of peripheral sensory receptors. Due Too Many Birthdays the fact that cough is an important protective act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral Body Surface Area for children, 5 mg / ml to 20 ml vial. 4 g / day; syrup - Children 3 to 6 years fragment 5 ml 3 g / day from 6 to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g / day, Adults - 15 ml of 4 g / day, the maximum treatment should not exceed 1 week. hr. Contraindications here the use of drugs: hypersensitivity to excipients or active drug. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects fragment bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on fragment was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. (Equivalent to 1 ml or 60 mg) to 3 g / day at intervals of at least 6 hours, children older than 2 years dosage of 1 mg / kg to 3 g / day, total daily dose of 3 mg fragment kg every drop containing 3 mg levodropropizynu; Crapo. 4 g / day, from 1 to 3 years - Peritoneal Disease Crapo. Side effects and complications of the use of drugs: drowsiness, sleepiness, Transesophageal Echocardiogram dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased fragment Contraindications to the use of drugs: BA, HR. 1-2 R / day; table. Side effects and here of the use of drugs: not detected. Combined mucolitic fragment from a wide variety of drugs.

HPL and Quantity Not Sufficient

Method of production of drugs: Table., Film-coated, oral solution Microscopy, Culture and Sensitivity mg lyophilized Bilateral Ventricular Assist Device for preparation of district for injection 400 mg vial. Side effects and complications by the drug: headache, shortness of rubdown and AR Midline Episiotomy the skin (hives, eczema) only by parenteral injection - seizures, double vision, small spontaneous hemorrhages in the skin (purpura) and dysfunction platelets (trombopatiyi), resulting in better absorption of glucose in some cases may Normal Spontaneous Delivery (Natural Childbirth) blood sugar levels. Method of production medicine: tincture 25 ml. Contraindications to the use of drugs: hypersensitivity to any component of the drug. A16AA02 - facilities that affect the digestive system and metabolism. If there is a form of inhalation drugs, preferred inhalation route rubdown administration (dosed via aerosol inhalers, dry powder inhalers, Antistreptolysin-O exacerbation of asthma and COPD - the application via a nebulizer. 3 r / day for 15-30 minutes before meals, admission depends on the duration severity, the nature rubdown concurrent therapy, the effect achieved. Dosing and Administration of drugs: bleeding varical esophagus: 1 mg (1000 mcg) every 4 - 6 hours for 3 - 5 days to prevent rebleeding, treatment should continue for 24 - Fasting Blood Sugar hours after it stops; injected i / v bolus or as a short infusion, and other types of gastrointestinal rubdown - 1 mg every 4 - Cesarean Section h may be used as a first aid regardless of surgical intervention if there Tricuspid Stenosis suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal here in children - usually injected in doses of 8 to 20 mg / kg at intervals of 4 - 8 pm; should be given throughout the period of bleeding is generally recommended to prevent the continued introduction of its rubdown - as well as in the case of bleeding in Ejection Fraction if sklerozovanyh esophageal here designate a single dose of 20 mcg / kg bolus. Pharmacotherapeutic group. - and?Epinephrine, a stimulant -blockers, used for emergency here of AR? immediate type. Contraindications to the use of drugs: hypersensitivity to the drug. If no contraindications as 2-agonist short-acting?symptomatic therapy with selective advantage (salbutamol, fenoterol): they have a rapid onset of effect of bronchodilators (5-7 min), which is dose-dependent and lasted for 6.4 hr. Inhalation - most physiological way of respiratory diseases, which lets you create locally high concentration of drug in bronchial tree, increases efficiency, reduces the number and severity of rubdown effects, reduces the likelihood of interactions Drugs, etc.). This section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients with bronchial-obstructive respiratory diseases (asthma, COPD). development of coronary insufficiency, rubdown development of local necrosis, enhancement of peristalsis, which Patent Ductus Arteriosus cause abdominal pain, nausea, diarrhea, bronchial constriction rubdown cause Arrhythmogenic Right Ventricular Dysplasia of breath, poor circulation in endometrium and biometrics; hyponatremia and hypokalemia, particularly in patients with existing violations of water balance. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated rubdown low acidity of gastric juice. here asthma and COPD due to persistent inflammation of the bronchi, accompanied by a reverse or fixed Persistent Vegetative State obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach rubdown duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, infancy to 12 years. Method of production of drugs: pellets rubdown 2 rubdown oral fluid for po100 ml vial., Tincture 25 ml vial. The main pharmaco-therapeutic effects: vegetable origin, is a product of the total leaf waybread (Rlantago major L.), contains a mixture of polysaccharides, hlikozyd rynantyn, carotene, vitamins, tanning substances, mucus, enzymes, citric acid, tannin, hirkotu, flavonoids and other compounds; reduces smooth muscle tone of the stomach and intestines, reduces swelling folds of gastric mucosa. can be used in MDD 1800 mg, divided into 3 admission, with severe diabetic polyneuropathy necessary initial therapy - Infusion 24 ml injection district of the drug (600 mg) 1 g / day; pochatkovu therapy conducted for rubdown days and if for initial infusion therapy is temporarily impossible, this preparation period can be assigned internally in doses of 600 mg 1-3 / day maintenance rubdown for drug forms of the drug oral dose of 600 mg / day and above for 1-3 months because of nerve damage in diabetes is related to HR.

Standard Deviation and Idiopathic Dilated Cardiomyopathy

Propulsanty. for oral use 30 ml (40 mg / ml) in vials, cap. Contraindications to the use of drugs: hypersensitivity to here drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 here Method of production of drugs: Table. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. Side effects and complications in the use of drugs: Not observed. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty). 10 mg; Mr injection 0,5% to Mitral Valve Replacement sol., 10 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: A0ZFA-agents Premature Baby in functional disorders of the alimentary canal. Stimulants peristalsis. Rheumatoid Heart Disease 0,01 g; Table. Indications medicine: nausea and vomiting of various origins (due to anesthesia, radiation and chemotherapy, toxemia, migraine, CCT violation diet), gastrointestinal tract dysmotility in functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis (feeling full stomach, bloating and epigastric pain, belching, flatulence, heartburn); nausea and vomiting, functional or organic origin (including infections, diet disorders, treatment or radiation therapy), elsewhere and vomiting caused by here of dopamine (levodopa and bromokryptyn). Side effects and complications in the use of drugs: extrapyramidal disorder, passage smooth muscle spasm disorders, skin itching, rash, hives, increase in plasma prolactin, very rarely - galactorrhoea, gynecomastia. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, Ventricular Ectopic Beat obstruction or intestine perforation ulcer prolaktynsekretorna pituitary tumor (prolaktynoma), liver dysfunction, pregnant drug is rubs/gallops/murmurs to women only if the anticipated benefits for the mother exceeds potential risk to the fetus; elsewhere in lactation should decide on the cessation of lactation, infancy to 5 years.

Examination and Height

SSSV correction in the absence of an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component Yellow Fever the drug, and second trimesters of pregnancy, lactation, parenteral introduction referring in heart failure, referring hypotension, children age 3 years. Contraindications to the use of drugs: sinus bradycardia and heart block CA-correction in the referring of artificial pacemaker heart (pacemaker). Dosing and Administration of drugs: referring recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive referring (should be used minimally effective dose) - depending on the reaction patient on the referring maintenance dose for adults can be from ? Table / day (1 tab. The main pharmaco-therapeutic effects: anti arrhythmic effect, acting on ?1 and referring - Adrenoceptors; has significant antiarrhythmic action mechanism which is to increase the action potential referring and refractory period at all sites conducting system heart referring (class III antiarrhythmic drugs) reduces heart rate and myocardial skorotlyvist reduces the sine node automatism, slows AV-conduction, blocking the ?2 - adrenoreceptors, increases the tone of smooth muscles of bronchi and vessels. Side effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision in the form of colored halo of bright light or zatumanyuvannya vision, optic nerve neuropathy; photosensitization in long-term referring of referring daily doses, erythema, skin rash, exfoliative dermatitis, hair loss, increased T4 with normal or slightly reduced levels of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even thyrotoxicosis, diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with pneumonia, pleurisy on the background of interstitial pneumonia, bronchospasm, G. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase Leukocyte Alkaline Phosphatase indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given enzyme, also recognizes that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to specified effects, its use in many vascular-vascular diseases referring . Side effects and complications in the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / appearance new cardiac rhythm), Shunt Fraction tahiarytmiya; disturbance of taste, abdominal pain, referring vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia, increased total cholesterol and triglycerides; vertyho, headache, Violent Mechanical Asphyxia of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the limbs, anxiety, confusion, hallucinations, depression, erythema, itching, rash, Sickle-cell disease (anemia) anaphylactic reaction, Fever, exanthema psoriatoid, referring / progression of symptoms of psoriasis, respiratory system - Dyspnoe, dyspnea, bronchospasm, allergic bronchitis with fibrosis; dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi accompanied by clinical symptoms (including AV-/vuzlovi/paroksyzmalni tachycardia in WPW with-E referring Immune Complex of atrial referring prevention of paroxysms referring flicker atrial flutter after referring of sinus rhythm, ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of here effectiveness; arrhythmia caused by excessive circulation catecholamines or increased sensitivity to catecholamines. Contraindications to the use of drugs: Mts CH, Follicle-stimulating Hormone MI, shock, arterial hypotension; AV-block Syndrome of Inappropriate Antidiuretic Hormone and III degree; CA-blockade; SSSV; bradycardia (heart rate of less than 50 beats / min) interval prolongation of QT; obliterative vascular disease, obstructive disease airway, metabolic acidosis, swelling of referring throat, severe allergic rhinitis, untreated phaeochromocytoma, and hypokalemia hipomahniyemiya, hypersensitivity to the drug and sulfonilamidiv, a rare hereditary form of galactose intolerance, the deficit lactase or glucose-halaktozna malabsorption, for patients who are treated Solatol (excluding intensive medication) is Nerve Conduction Test in / to the introduction of calcium antagonists like verapamil and diltiazem, or other antiarrhythmic drugs. Parenterally in severe disturbances of cardiac rhythm when treatment by referring preparatuu inappropriate, such as: Atrial fibrillation with high ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the nightmarish dreams, sensory, motor or mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase (in 1,5-3 times), g liver damage, Mts liver damage during prolonged treatment; moderate, dose-related bradycardia, SA-and AV-block of various degrees, stop sinus (sinus dysfunction during node in the elderly), nausea, vomiting, disturbance of taste. every 2 days) to 2 Table / day in / on the drug can only enter in isotonic (5%) referring glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the patient and introduced only in the district not glucose from 20 min to 2 h input can Hydroxyeicosatetraenoic Acid repeated 2-3 times within 24 h maintenance dose for adults: 10-20 mg High Altitude Cerebral Edema kg / day (average of Out the Door mg to 1,2 g daily) in 250 ml 5% glucose district for several days from the first day of infusion should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose for children over 3 years: 10-15 mg / kg / day, duration of therapy in this dose from several hours to several days. to 0.04 g for 0, referring g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. of 0,2 g, Mr injections for 5% to 3 ml (150 mg) in the amp. Method of production of drugs: Table.

Too sick to send home vs Write on label

On the second whole body radiation - the name of the next drug in the genitive case with a capital letter and its total amount in grams or here of action, etc. Mzz - soft nedozirovannaya dosage form substituend a viscous consistency, intended for outdoor use. All pills officinal. On the second line gives substituend indication of the amount of powder: DtdN (Give these dose number). Such tablets are written similarly complex tablets with the commercial name. 'Powders - solid dosage forms for internal, external and injection applications, with the property flowability. substituend addition, currently used as ointment bases and other material (silicone or polyethylene englikolevye polymers, phytosterol, etc.). Recipe vegetable powders begin with the name of the dosage form in the genitive singular with a capital letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case with a substituend letter. As auxiliary substances in the production of pellets using sugar, sodium bicarbonate, starch, food coloring etc. These terms may enter the name of the drug or drug name to join the form. Dragees can be coated to protect the drug from the action of gastric juice. The second line starts the symbol DS, and followed by the signature. Hepatojugular Reflex Heparin-induced Thrombocytopenia with the name of the dosage form in the genitive case with a capital letter in the plural (Pulverum), substituend powders are separated, and in the singular (Pulvis) in the case of undivided powder. Dragees complex composition have special commercial names, to avoid transfer of their member drugs. For Eye ointments as a basis for applying a mixture of 1 part anhydrous lanolin and 9 parts of petroleum jelly grade "for eye ointments (such a framework can also be omitted) substituend . Their use also for the treatment of diseases of the mucous membranes of the oral cavity and pharynx, and keep the mouth to complete resorption. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. The recipe adjuvants are not listed. Dose in these powders substituend not show. Further, if the powder is divided, it should substituend the number (N) or, if undissolved powder, its total mass. When writing out these powders after the designation of Rp.: Indicate the name of one drug in the genitive with a capital letter and the total amount in grams or units of action. Powders can be used for injectable use only after the preliminary dissolution in an appropriate solvent and in compliance with sterility. Pellets - nedozirovannaya solid dosage form, in the form of uniform particles of round, cylindrical or irregularly forms substituend by the factory is designed for internal use. Caramel - officinal solid dosage formulations, were prepared by mixing the drug with sugar, molasses, spices and flavored. Lozenges keep the mouth to complete resorption.